Please see the following information about the current Cerezyme supply shortage as well as information about alternate therapies for Gaucher patients.
Genzyme Corporation contact information: Genzyme Medical Information: email@example.com or 1-800-745-4447, option 2
Please see the web sites listed below for additional information:
- Genzyme supply update
- Treatment Protocol of Velaglucerase Alfa
- Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease